Ovom Care is a technology company.
Ovom Care has raised $5.0M across 1 funding round.
Ovom Care has raised $5.0M in total across 1 funding round.
Ovom Care has raised $5.0M in total across 1 funding round.
Ovom Care's investors include Alpha Intelligence Capital, Ananda Impact Ventures.
# High-Level Overview
Ovom Care is a medtech company that combines AI-enabled fertility clinics with proprietary technology to improve reproductive care outcomes.[1][4] The company operates a hybrid business model integrating digital-first fertility clinics with advanced artificial intelligence solutions, addressing a critical gap in reproductive healthcare where approximately 1 in 6 couples experience infertility and only 35% of IVF treatments succeed on average.[1]
Ovom serves individuals and couples seeking fertility treatment by offering world-class reproductive care—including IVF, egg freezing, and related services—delivered through a patient-centric approach that combines cutting-edge technology with compassionate medical expertise.[2][5] The company's core mission is making fertility care accessible, personal, and effective regardless of geographic location or personal circumstances.[2] By collecting high-quality fertility data through its clinical operations, Ovom simultaneously builds a proprietary dataset that positions it for future AI-driven innovation in reproductive medicine.[3]
# Origin Story
Ovom was founded in 2023 by an all-female leadership team with deep expertise in fertility and healthcare innovation.[1][3] The founders are Felicia von Reden (CEO), Dr. Lynae Brayboy (CMO), and Dr. Cristina Hickman (COO), collectively bringing over 40 years of combined experience.[3] Dr. Brayboy is a double-certified reproductive endocrinologist, while Dr. Hickman is a clinical embryologist with 20+ years of experience and recognized as the "Godmother of AI in fertility treatments" for her role in building 13 IVF clinics and co-developing AI technologies applied in fertility medicine.[3] Von Reden is a 2x founder of neo-clinic startups, bringing entrepreneurial experience to the venture.[3]
The company emerged from observing systemic failures in traditional fertility care: rushed appointments, confusing processes, and inadequate support during critical treatment phases.[2] This insight drove the founders to design a fundamentally different model—one that unites top fertility specialists, cutting-edge AI, and genuinely human-centered care. Ovom received its first investment in 2024 and has since raised €4.8 million in seed funding, with total funding reaching $6.6 million.[1][4]
# Core Differentiators
# Role in the Broader Tech Landscape
Ovom exemplifies the convergence of femtech, AI-driven healthcare, and clinical operations—a trend reshaping how reproductive medicine is delivered. The company rides several powerful waves: the global infertility crisis affecting millions, the proven efficacy of AI in medical diagnostics and treatment optimization, and growing demand for patient-centric healthcare experiences.
The timing is particularly significant because fertility care has historically been fragmented between high-cost clinics and limited data infrastructure, leaving room for AI-enabled disruption. By controlling both the clinical data source and the AI layer, Ovom avoids the common startup trap of building technology without real-world validation. This positions the company to influence the broader ecosystem by establishing new standards for data-driven reproductive medicine and potentially licensing its AI capabilities to other fertility providers globally.
# Quick Take & Future Outlook
Ovom is well-positioned to become a category leader in AI-enabled fertility care, particularly as it scales clinic operations across Europe and builds its proprietary dataset. The company's next critical milestones include expanding its clinic footprint, demonstrating measurable improvements in treatment success rates, and potentially monetizing its AI technology beyond its own clinics.
The broader trend favoring this company is the intersection of healthcare consolidation, AI adoption in medicine, and the growing acceptance of fertility treatment as essential healthcare. As Ovom proves its hybrid model works—delivering both superior patient outcomes and valuable data assets—it may inspire similar vertical integration strategies in other specialized medical domains. The company's success will ultimately hinge on translating its technological advantages into sustained clinical outcomes and sustainable unit economics across multiple geographies.
Ovom Care has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2024 | $5.0M Seed | Alpha Intelligence Capital, Ananda Impact Ventures |